Life sciences news
-
Belgian biotech in European Top-3 despite turbulent times
Wednesday May 18th 2022
Read more
-
KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus
Wednesday May 18th 2022
Read more
-
flanders.bio appoints CEO and COO in newly created role
Wednesday May 18th 2022
Read more
-
Spearhead cluster flanders.healthTech turns into MEDVIA and is ready to make a change in healthcare innovation
Tuesday May 17th 2022
Read more
-
QbD Group requalifies as Best Managed Company
Friday May 13th 2022
Read more
-
Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions
Thursday May 12th 2022
Read more
-
Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic
Thursday May 12th 2022
Read more
-
Augustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications
Tuesday May 10th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis
Tuesday May 10th 2022
Read more
-
Quality by Design (QbD) becomes QbD Group, consolidating its offerings to support the development of innovative life science products, “from idea to patient”
Monday May 9th 2022
Read more
-
Oxurion announces top-line results from Part A of Phase 2 INTEGRAL trial evaluating THR-687 for treatment of diabetic macular edema (DME)
Monday May 9th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
